| 1. Capková K, Yoneda Y, Dickerson TJ, Janda KD.. (2007) Synthesis and structure-activity relationships of second-generation hydroxamate botulinum neurotoxin A protease inhibitors., 17 (23): [PMID:17951059] [10.1016/j.bmcl.2007.09.103] |
| 2. Eubanks LM, Hixon MS, Jin W, Hong S, Clancy CM, Tepp WH, Baldwin MR, Malizio CJ, Goodnough MC, Barbieri JT, Johnson EA, Boger DL, Dickerson TJ, Janda KD.. (2007) An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists., 104 (8): [PMID:17293454] [10.1073/pnas.0611213104] |
| 3. Moe ST, Thompson AB, Smith GM, Fredenburg RA, Stein RL, Jacobson AR.. (2009) Botulinum neurotoxin serotype A inhibitors: small-molecule mercaptoacetamide analogs., 17 (8): [PMID:19329331] [10.1016/j.bmc.2009.03.013] |
| 4. Burnett JC, Wang C, Nuss JE, Nguyen TL, Hermone AR, Schmidt JJ, Gussio R, Wipf P, Bavari S.. (2009) Pharmacophore-guided lead optimization: the rational design of a non-zinc coordinating, sub-micromolar inhibitor of the botulinum neurotoxin serotype a metalloprotease., 19 (19): [PMID:19703771] [10.1016/j.bmcl.2009.01.111] |
| 5. Capková K, Hixon MS, Pellett S, Barbieri JT, Johnson EA, Janda KD.. (2010) Benzylidene cyclopentenediones: First irreversible inhibitors against botulinum neurotoxin A's zinc endopeptidase., 20 (1): [PMID:19914829] [10.1016/j.bmcl.2009.10.129] |
| 6. Li B, Pai R, Cardinale SC, Butler MM, Peet NP, Moir DT, Bavari S, Bowlin TL.. (2010) Synthesis and biological evaluation of botulinum neurotoxin a protease inhibitors., 53 (5): [PMID:20155918] [10.1021/jm901852f] |
| 7. Smith GR, Caglič D, Capek P, Zhang Y, Godbole S, Reitz AB, Dickerson TJ.. (2012) Reexamining hydroxamate inhibitors of botulinum neurotoxin serotype A: extending towards the β-exosite., 22 (11): [PMID:22542019] [10.1016/j.bmcl.2012.04.019] |
| 8. Silhár P, Lardy MA, Hixon MS, Shoemaker CB, Barbieri JT, Struss AK, Lively JM, Javor S, Janda KD.. (2013) The C-terminus of Botulinum A Protease Has Profound and Unanticipated Kinetic Consequences Upon the Catalytic Cleft., 4 (2): [PMID:23565325] [10.1021/ml300428s] |
| 9. Šilhár P, Silvaggi NR, Pellett S, Čapková K, Johnson EA, Allen KN, Janda KD.. (2013) Evaluation of adamantane hydroxamates as botulinum neurotoxin inhibitors: synthesis, crystallography, modeling, kinetic and cellular based studies., 21 (5): [PMID:23340139] [10.1016/j.bmc.2012.12.001] |
| 10. Day JA, Cohen SM.. (2013) Investigating the selectivity of metalloenzyme inhibitors., 56 (20): [PMID:24074025] [10.1021/jm401053m] |
| 11. Videnović M, Opsenica DM, Burnett JC, Gomba L, Nuss JE, Selaković Z, Konstantinović J, Krstić M, Segan S, Zlatović M, Sciotti RJ, Bavari S, Solaja BA.. (2014) Second generation steroidal 4-aminoquinolines are potent, dual-target inhibitors of the botulinum neurotoxin serotype A metalloprotease and P. falciparum malaria., 57 (10): [PMID:24742203] [10.1021/jm500033r] |
| 12. Ai T, Xu Y, Qiu L, Geraghty RJ, Chen L.. (2015) Hydroxamic acids block replication of hepatitis C virus., 58 (2): [PMID:25490700] [10.1021/jm501330g] |
| 13. Hermant P, Bosc D, Piveteau C, Gealageas R, Lam B, Ronco C, Roignant M, Tolojanahary H, Jean L, Renard PY, Lemdani M, Bourotte M, Herledan A, Bedart C, Biela A, Leroux F, Deprez B, Deprez-Poulain R.. (2017) Controlling Plasma Stability of Hydroxamic Acids: A MedChem Toolbox., 60 (21): [PMID:28985084] [10.1021/acs.jmedchem.7b01444] |
| 14. Zhou Y, McGillick BE, Teng YG, Haranahalli K, Ojima I, Swaminathan S, Rizzo RC.. (2016) Identification of small molecule inhibitors of botulinum neurotoxin serotype E via footprint similarity., 24 (20): [PMID:27543389] [10.1016/j.bmc.2016.07.031] |
| 15. Lin L,Olson ME,Sugane T,Turner LD,Tararina MA,Nielsen AL,Kurbanov EK,Pellett S,Johnson EA,Cohen SM,Allen KN,Janda KD. (2020) Catch and Anchor Approach To Combat Both Toxicity and Longevity of Botulinum Toxin A., 63 (19.0): [PMID:32886509] [10.1021/acs.jmedchem.0c01006] |
| 16. Turner, Lewis D., Nielsen, Alexander L., Lin, Lucy, Pellett, Sabine, Sugane, Takashi, Olson, Margaret E., Johnson, Eric A., Janda, Kim D.. (2021) Irreversible inhibition of BoNT/A protease: proximity-driven reactivity contingent upon a bifunctional approach, 12 (6.0): [PMID:34223161] [10.1039/d1md00089f] |
| 17. Turner LD, Nielsen AL, Lin L, Campedelli AJ, Silvaggi NR, Chen JS, Wakefield AE, Allen KN, Janda KD.. (2021) Use of Crystallography and Molecular Modeling for the Inhibition of the Botulinum Neurotoxin A Protease., 12 (8.0): [PMID:34413962] [10.1021/acsmedchemlett.1c00325] |
| 18. Patel EN, Turner LD, Hixon MS, Janda KD.. (2022) Identification of Slow-Binding Inhibitors of the BoNT/A Protease., 13 (4.0): [PMID:35450355] [10.1021/acsmedchemlett.2c00028] |
| 19. Hou R, He Y, Yan G, Hou S, Xie Z, Liao C.. (2021) Zinc enzymes in medicinal chemistry., 226 [PMID:34624823] [10.1016/j.ejmech.2021.113877] |
